Skip to main content
. 2022 Jul 31;11(8):866. doi: 10.3390/pathogens11080866

Table 5.

Factors associated with pretreatment HIVDR among newly reported HIV infections.

Variable Number Drug Resistance,
n (%)
OR * (95% CI) p AOR * (95% CI) p
Total 816 52 (6.4)
Age (years)
18–29 318 17 (5.3) 1.00
30–39 147 9 (6.1) 1.16 (0.50–0.66) 0.735
40–49 100 6 (6.0) 1.13 (0.43–2.95) 0.803
≥50 121 12 (9.9) 1.95 (0.90–4.21) 0.090
Unknown 130 8 (6.2) 1.16 (0.49–2.76) 0.736
Sex
Male 627 39 (6.2) 1.00
Female 59 5 (8.5) 1.40 (0.53–3.69) 0.501
Unknown 130 8 (6.2) 0.99 (0.45–2.17) 0.977
Ethnicity
Han 680 44 (6.5) 1.00
Other 6 0 (0.0) - -
Unknown 130 8 (6.2) 0.95 (0.44–2.06) 0.893
Education
Illiterate 81 4 (4.9) 1.00
Primary or junior high school 143 15 (10.5) 2.26 (0.72–7.04) 0.161
Senior high school or higher 462 25 (5.4) 1.10 (0.37–3.25) 0.861
Unknown 130 8 (6.2) 1.26 (0.37–4.33) 0.711
Marital status
Single 379 20 (5.3) 1.00
Married 210 14 (6.7) 1.28 (0.63–2.59) 0.490
Divorced/widowed 97 10 (10.3) 2.06 (0.93–4.57) 0.074
Unknown 130 8 (6.2) 1.18 (0.51–2.74) 0.705
Route of infection *
MSM 505 29 (5.7) 1.00
HET 178 15 (8.4) 1.51 (0.79–2.89) 0.212
IDU 3 0 (0.0) - -
Unknown 130 8 (6.1) 1.08 (0.48–2.41) 0.858
Subtype
CRF55_01B 51 6 (11.8) 1.00 1.00
CRF01_AE-cluster 4 199 8 (4.0) 0.31 (0.10–0.95) 0.040 0.26 (0.08–0.81) 0.021
CRF01_AE-cluster 5 66 3 (4.5) 0.36 (0.09–1.50) 0.160 0.33 (0.07–1.42) 0.036
CRF07_BC-N 285 15 (5.2) 0.42 (0.15–1.13) 0.086 0.35 (0.12–0.98) 0.045
Other 215 20 (9.3) 0.77 (0.29–2.03) 0.595 0.60 (0.21–1.70) 0.334
CD4 count before ART (cells/µL)
<200 214 15 (7.0) 1.00
200–350 196 13 (6.6) 0.94 (0.44–2.03) 0.880
350–500 140 7 (5.0) 0.70 (0.28–1.76) 0.446
>500 136 9 (6.6) 0.94 (0.40–2.21) 0.888
Unknown 130 8 (6.2) 0.87 (0.36–2.11) 0.758
Sampling time
2017 66 4 (6.1) 1.00
2018 162 8 (4.9) 0.81 (0.23–2.77) 0.731
2019 215 10 (4.7) 0.76 (0.23–2.50) 0.646
2020 373 30 (8.0) 1.36 (0.46–3.98) 0.580

* OR, odds ratio. AOR, adjusted odds ratio. MSM, men who have sex with men; HET, heterosexual; IDU, injecting drug users.